Fortical and Pain exacerbated - a phase IV clinical study of FDA data

Summary:

Pain exacerbated is reported as a side effect among people who take Fortical (calcitonin salmon recombinant), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Miacalcin, and have Emphysema.

The phase IV clinical study analyzes which people have Pain exacerbated when taking Fortical. It is created by eHealthMe based on reports of 487 people who have side effects when taking Fortical from the FDA, and is updated regularly.

What is Fortical?

Fortical has active ingredients of calcitonin salmon recombinant. eHealthMe is studying from 494 Fortical users. Check the latest studies of Fortical.

What is Pain exacerbated?

Pain exacerbated is found to be associated with 3,987 drugs and 3,019 conditions by eHealthMe. Check the latest studies of Pain exacerbated.

On Jul, 13, 2026

487 people reported to have side effects when taking Fortical.
Among them, 76 people (15.61%) have Pain exacerbated.

Among these 76 people:

How long have people been on Fortical when they have Pain exacerbated? *

What is the gender of people who have Pain exacerbated when taking Fortical? *

female: 72 %
male: 28 %

What is the age of people who have Pain exacerbated when taking Fortical? *

What are other drugs people take besides Fortical? *

What are other side effects people have besides Pain exacerbated? *

Stress And Anxiety: 55 people, 72.37%
High Blood Pressure: 43 people, 56.58%
Anaemia (lack of blood): 41 people, 53.95%
Acute Kidney Failure: 40 people, 52.63%
Osteoporosis (bones weak and more likely to break): 40 people, 52.63%
Injury: 40 people, 52.63%
Osteopenia (a condition where bone mineral density is lower than normal): 38 people, 50.00%
Osteonecrosis Of Jaw (death of bone of jaw): 37 people, 48.68%
Dehydration (dryness resulting from the removal of water): 36 people, 47.37%
Atelectasis (partial or complete collapse of the lung): 36 people, 47.37%

What are the existing conditions these people have? *

High Blood Pressure: 16 people, 21.05%
Depression: 16 people, 21.05%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 16 people, 21.05%
Osteoporosis (bones weak and more likely to break): 7 people, 9.21%
Arrhythmias (irregular heartbeat): 5 people, 6.58%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 3 people, 3.95%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 3.95%
Stress And Anxiety: 3 people, 3.95%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 2 people, 2.63%
Cardiac Disorder: 2 people, 2.63%

* Approximation only. Some reports may have incomplete information.

Do you take Fortical and have Pain exacerbated?

- Check whether Pain exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fortical:

Fortical (494 reports)

Browse all side effects of Fortical:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pain exacerbated:

Pain exacerbated (3,987 drugs)

Browse all the conditions that are associated with Pain exacerbated:

Pain exacerbated (3,019 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on calcitonin salmon recombinant (the active ingredients of Fortical) and Fortical (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.